Who
Mark A. Wan
Director
Company insider
Files Form 4 as: Director and 10% owner, Talphera; 10% owner, Concert Pharmaceuticals; Director, Epocrates; 10% owner, Liposcience.
In numbers
- Trades disclosed
- 75
- Buys
- 2
- Sells
- 3
- Bought
- $3.4M
- Sold
- $17.0M
- Companies
- 4
- Companies where not an officer
- 4
- First trade
- 7 Feb 2011
- Last trade
- 22 Jun 2026
- Last filed
- 24 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 22 Jun 2026filed 24 Jun 2026 | TLPH TalpheraBiotechnology | SEC FORM 4 Code A | —5,100 at $0.00 | filing |
| 22 Jun 2026filed 24 Jun 2026 | TLPH Talpheraoption or derivative · Biotechnology | SEC FORM 4 Code A | —30,700 at $0.00 | filing |
| 22 Jun 2026filed 24 Jun 2026 | TLPH Talpheraoption or derivative · Biotechnology | SEC FORM 4 Code A | —30,700 at $0.00 | filing |
| 22 Jun 2026filed 24 Jun 2026 | TLPH TalpheraBiotechnology | SEC FORM 4 Code A | —5,100 at $0.00 | filing |
| 23 Oct 2025filed 24 Oct 2025 | TLPH Talpheraoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,600 at $0.00 | filing |
| 23 Oct 2025filed 24 Oct 2025 | TLPH TalpheraBiotechnology | SEC FORM 4 Code A | —4,267 at $0.00 | filing |
| 24 Jun 2024filed 24 Jun 2024 | TLPH Talpheraoption or derivative · Biotechnology | SEC FORM 4 Code A | —13,044 at $0.00 | filing |
| 24 Jun 2024filed 24 Jun 2024 | TLPH TalpheraBiotechnology | SEC FORM 4 Code A | —2,174 at $0.00 | filing |
| 10 Oct 2023filed 13 Dec 2023 | TLPH Talpheraoption or derivative · Biotechnology | SEC FORM 4 Code A | —3,487 at $0.00 | filing |
| 10 Oct 2023filed 13 Dec 2023 | TLPH TalpheraBiotechnology | SEC FORM 4 Code A | —581 at $0.00 | filing |
| 15 Jul 2022filed 15 Jul 2022 | TLPH Talpheraoption or derivative · Biotechnology | SEC FORM 4 Code A | —31,000 at $0.00 | filing |
| 15 Jul 2022filed 15 Jul 2022 | TLPH TalpheraBiotechnology | SEC FORM 4 Code A | —15,500 at $0.00 | filing |
| 17 Jun 2021filed 17 Jun 2021 | TLPH TalpheraBiotechnology | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 17 Jun 2021filed 17 Jun 2021 | TLPH Talpheraoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 16 Jun 2020filed 16 Jun 2020 | TLPH Talpheraoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 16 Jun 2020filed 16 Jun 2020 | TLPH TalpheraBiotechnology | SEC FORM 4 Code A | —7,500 at $0.00 | filing |
| 25 Jun 2019filed 25 Jun 2019 | TLPH Talpheraoption or derivative · Biotechnology | SEC FORM 4 Code A | —7,500 at $0.00 | filing |
| 25 Jun 2019filed 25 Jun 2019 | TLPH TalpheraBiotechnology | SEC FORM 4 Code A | —3,750 at $0.00 | filing |
| 14 Jun 2018filed 14 Jun 2018 | TLPH Talpheraoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 15 Jun 2017filed 15 Jun 2017 | TLPH Talpheraoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
News
Evolus (NASDAQ:EOLS) & Talphera (NASDAQ:TLPH) Financial ComparisonTLPH · dailypolitical.com · 13 Oct 2026
0 headlines in the last 90 days name Mark A. Wan; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.